Cook Robert Christopher bought 121,575 shares of FILANA THERAPEUTICS, INC. at $0.46 for $55.9k on Nov 16, 2026

Buy
Form 4 code P. Open-market or private purchase of a non-derivative or derivative security.
Chief Operating& Legal Officer
Chief Operating& Legal Officer
Filed Nov 18, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
$55,924.50Shares × reported price
Shares traded
121,575Common Stock
Price per share
$0.46Reported price. Read footnotes for ranges.
% of reported position traded
885.79%This security and ownership context
Holdings after
135,300Direct
Trade date
Nov 16, 2026Buy
Filed
Nov 18, 2026, 4:05 PM ET2-day reporting delay
Accession
0001437749-26-037544Code P · Transaction 405658
How reported position traded is calculated

Shares purchased ÷ (holdings after − shares purchased). Estimated position before: 13,725 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

No other transaction rows in this filing.

1 transaction row in this filing. Joint filers share the same rows.

FLNA price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
FLNA · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.

Return windows are pending. The first 7-day window is eligible on Nov 25, 2026. Values appear when the daily price refresh supplies a valid close for that window. Weekends, market holidays and missing prices can delay updates.

Pre-filing1mo ago +46%1w ago +29%1d ago −13%
Returns since7d30d90d180d1y

Footnotes in full

F1: The purchase reported in column 4 is a weighted average price. The shares were purchased in multiple open market transactions at prices ranging from $0.40 to $0.48 per share. The reporting person undertakes to provide to Filana, any security holder of Filana or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each price within the range set forth in this footnote.